Alnylam Pharmaceuticals, Inc.
81
Plan:
Alnylam Pharmaceuticals, Inc. Savings & Investment Plan
12
75
88
0
10
20
30
40
50
60
70
80
90
100
For the average 401k participant, the 7 point difference between this plan's BrightScope Rating (81) and the top rated plan (88) could equate to:
[How is this calculated?]
[How is this calculated?]
5 additional years of workThe delay in retirement calculations apply solely to this defined contribution plan and do not take into account other retirement plans and programs offered by this employer.
Retirement Plan Description
Alnylam Pharmaceuticals, Inc. Savings & Investment Plan is a defined contribution plan with a 401k feature. This plan has a BrightScope Rating of 81. This plan is in the top 15% of plans for Salary Deferral. Alnylam Pharmaceuticals, Inc. Savings & Investment Plan currently has over 200 active participants and over $9.4M in plan assets.
Retirement Plan Details
| Address |
300 Third Street
3rd Floor Cambridge, MA 02142 |
| Industry | Professional, Scientific, and Technical Services |
| Administrator | Michael Mason |
| Net Plan Assets | $9,400,000 |
| Total Participants | 230 |
| Avg Account Balance | $40,000 |
Compare Other Companies in Peer Group
| Infinity Pharmaceuticals | 82.2 |
| Aveo Pharmaceuticals | 79.9 |
| Cato Research Ltd. | 75.4 |
| Averion International | 74.2 |
| Northern California Institute for... | 70.4 |
| Boston IVF | 68.0 |
Comments